Understanding how often the bleeding events occur in the subjects who voluntarily decide to switch from prophylaxis to on-demand and in those subjects who remain on prophylaxis. Also look into the consequences of switching treatment in QoL (quality of life), development of target joints, activity level and reasons that might influence the desire to switch.
Study Type
OBSERVATIONAL
Enrollment
38
Subjects electing to stay on the prophylactic treatment (prospective)
Subjects electing to switch to on-demand treatment (prospective)
Subjects remaining on-demand treatment (retrospective)
Unnamed facility
Duarte, California, United States
Unnamed facility
Denver, Colorado, United States
Unnamed facility
Peoria, Illinois, United States
Unnamed facility
Jefferson City, Missouri, United States
To evaluate the frequency of all bleeds (spontaneous and trauma) during the study
Time frame: End of Study
To evaluate the change from baseline in HRQoL (health-related quality of life)
Time frame: End of Study
To evaluate number of patients that want to return to prophylaxis treatment after having switched to on-demand therapy
Time frame: End of Study
To evaluate the change from baseline in the Gilbert score
Time frame: End of Study
To evaluate the number of target joint development
Time frame: End of Study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Las Vegas, Nevada, United States
Unnamed facility
Fort Worth, Texas, United States
Unnamed facility
Houston, Texas, United States
Unnamed facility
Many Locations, Canada
Unnamed facility
Many Locations, Germany
Unnamed facility
Many Locations, United Kingdom